On Monday, Tenaya Therapeutics Inc (NASDAQ: TNYA) was -6.88% drop from the session before settling in for the closing price of $2.76. A 52-week range for TNYA has been $1.61 – $7.01.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
When this article was written, the company’s average yearly earnings per share was at 19.57%. With a float of $65.58 million, this company’s outstanding shares have now reached $68.33 million.
The extent of productivity of a business whose workforce counts for 140 workers is very important to gauge. In terms of profitability, gross margin is 58.87%, operating margin of -694.87%, and the pretax margin is -663.65%.
Tenaya Therapeutics Inc (TNYA) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Tenaya Therapeutics Inc stocks. The insider ownership of Tenaya Therapeutics Inc is 17.22%, while institutional ownership is 56.90%. The most recent insider transaction that took place on Aug 16 ’24, was worth 6,840. In this transaction SVP, Accounting and Fin. Ops. of this company sold 2,363 shares at a rate of $2.89, taking the stock ownership to the 63,241 shares. Before that another transaction happened on Aug 16 ’24, when Company’s Chief Medical Officer sold 7,428 for $2.89, making the entire transaction worth $21,500. This insider now owns 107,106 shares in total.
Tenaya Therapeutics Inc (TNYA) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 19.57% per share during the next fiscal year.
Tenaya Therapeutics Inc (NASDAQ: TNYA) Trading Performance Indicators
You can see what Tenaya Therapeutics Inc (TNYA) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 5.27.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.48, a number that is poised to hit -0.31 in the next quarter and is forecasted to reach -1.25 in one year’s time.
Technical Analysis of Tenaya Therapeutics Inc (TNYA)
The latest stats from [Tenaya Therapeutics Inc, TNYA] show that its last 5-days average volume of 6.48 million was superior to 0.77 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 65.38%. Additionally, its Average True Range was 0.31.
During the past 100 days, Tenaya Therapeutics Inc’s (TNYA) raw stochastic average was set at 39.18%, which indicates a significant decrease from 57.25% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 137.49% in the past 14 days, which was higher than the 99.28% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.04, while its 200-day Moving Average is $3.65. Now, the first resistance to watch is $2.92. This is followed by the second major resistance level at $3.26. The third major resistance level sits at $3.50. If the price goes on to break the first support level at $2.34, it is likely to go to the next support level at $2.10. The third support level lies at $1.76 if the price breaches the second support level.
Tenaya Therapeutics Inc (NASDAQ: TNYA) Key Stats
There are 78,889K outstanding shares of the company, which has a market capitalization of 224.77 million. As of now, sales total 0 K while income totals -124,080 K. Its latest quarter income was 0 K while its last quarter net income were -29,430 K.
